Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

HOLX Relative to the S&P 500

HOLX Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Hologic, Inc. (NASD:HOLX) seasonal charts above shows that a Buy Date of November 12 and a Sell Date of February 5 has resulted in a geometric average return of 7.66% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 18 of those periods. This is an excellent rate of success and the return slightly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 0.73% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm’s revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

To download HOLX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: HOLX